CAS NO: | 112727-80-7 |
包装 | 价格(元) |
5mg | 电议 |
10mg | 电议 |
50mg | 电议 |
100mg | 电议 |
生物活性 | Renzapride (BRL 24924), a substituted benzamide, is a full5-HT4receptoragonist with aKivalue of 115 nM. Renzapride (BRL 24924) is also a5HT2band5HT3 receptorantagonist[1]. Renzapride could be used for constipation predominant irritable bowel syndrome (C-IBS) study[2]. | ||||||||||||||||
IC50& Target[1] |
| ||||||||||||||||
体外研究 (In Vitro) | Renzapride replaces specific binding of [H3] GR 113808 (a selective 5-HT receptor antagonist) to cloned human 5-HT4receptors with a Kivalue of 115 nM[3]. | ||||||||||||||||
体内研究 (In Vivo) | Renzapride (BRL 24924) (100 μg i.v.) results in a partial reverse of both the delayed solid and liquid meals emptying[2].
| ||||||||||||||||
Clinical Trial | |||||||||||||||||
分子量 | 323.82 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C16H22ClN3O2 | ||||||||||||||||
CAS 号 | 112727-80-7 | ||||||||||||||||
中文名称 | 伦扎必利 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 |
|